A Busy Week for Multiple Sclerosis News
It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate.
bayer
No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business
Patients hoping for a new alternative to the blockbuster blood thinner Plavix will have to wait a bit longer for a verdict on a promising candidate.
Making Diabetes Less Painful to Deal With
Diabetes patients don’t always engage in the self-care needed to control the disease.
Echo Therapeutics: Positive Developments for Needle-Free Monitoring System
On 11/19/09, the Company announced positive results in a pilot clinical study which included Prelude skin preparation and the placement of 10 Symphony tCGM biosensors on subjects with Type 1 or Type 2 Diabetes.
Onyx Pharmaceuticals to Acquire Proteolix
Onyx Pharmaceuticals has agreed to purchase private biotechnology company Proteolix for $276 million in cash.
New Developments in Detecting and Treating Alzheimer’s
Every 70 seconds, someone develops Alzheimer’s disease. This startling figure from the Alzheimer’s Association underlines the desperate need for new tools to diagnose and treat this debilitating illness.